Most sold healthcare stocks in Q3 2020
See which Healthcare stocks institutional investors trimmed or exited the most in Q3 2020, measured as net reductions in reported share positions from Q2 2020 into Q3 2020. Notable reductions at the top of this list include AKEBIA THERAPEUTICS INC (AKBA), GRIFOLS SA-ADR (GRFS), ASTRAZENECA PLC-SPONS ADR (AZN), BAUSCH HEALTH COS INC (BHC). These rankings are based on SEC 13F filings from the investors we track.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| AKBA | AKEBIA THERAPEUTICS INC | -15,005,514 | -$267.17K | 0 | 0 | 1 | 1 | 2 |
| GRFS | GRIFOLS SA-ADR | -11,960,262 | -$218.50K | 0 | 1 | 0 | 1 | 1 |
| AZN | ASTRAZENECA PLC-SPONS ADR | -6,694,006 | -$324.49K | 0 | 1 | 2 | 0 | 3 |
| BHC | BAUSCH HEALTH COS INC | -4,381,099 | -$153.38K | 0 | 1 | 1 | 0 | 4 |
| BAX | BAXTER INTERNATIONAL INC | -4,318,412 | -$376.89K | 2 | 2 | 2 | 1 | 7 |
| NVST | ENVISTA HOLDINGS CORP | -3,778,242 | -$54.95K | 0 | 1 | 0 | 1 | 1 |
| HCA | HCA HEALTHCARE INC | -3,752,923 | -$272.80K | 0 | 1 | 1 | 3 | 2 |
| TEVA | TEVA PHARMACEUTICAL-SP ADR | -2,733,979 | -$286.51K | 0 | 1 | 2 | 0 | 5 |
| DVA | DAVITA INC | -2,651,722 | $25.31K | 0 | 0 | 2 | 1 | 3 |
| INVA | INNOVIVA INC | -2,190,494 | -$60.26K | 0 | 0 | 1 | 1 | 1 |
| SDGR | SCHRODINGER INC | -1,633,954 | -$395.16K | 0 | 2 | 1 | 0 | 3 |
| ALGN | ALIGN TECHNOLOGY INC | -1,619,275 | -$100.89K | 0 | 1 | 5 | 1 | 6 |
| OSUR | ORASURE TECHNOLOGIES INC | -1,536,140 | -$16.60K | 0 | 0 | 1 | 0 | 1 |
| HALO | HALOZYME THERAPEUTICS INC | -1,514,651 | -$41.17K | 0 | 0 | 3 | 0 | 3 |
| AMRN | AMARIN CORP PLC -ADR | -1,209,313 | -$15.58K | 1 | 0 | 1 | 1 | 2 |
| MCRB | SERES THERAPEUTICS INC | -1,202,401 | $292.65K | 0 | 0 | 2 | 0 | 2 |
| LAB | STANDARD BIOTOOLS INC | -1,157,800 | $2.91K | 0 | 0 | 1 | 0 | 1 |
| AMGN | AMGEN INC | -1,073,023 | -$232.60K | 0 | 3 | 3 | 0 | 6 |
| ELAN | ELANCO ANIMAL HEALTH INC | -1,066,729 | $4.63K | 0 | 1 | 1 | 0 | 2 |
| TGTX | TG THERAPEUTICS INC | -1,056,800 | -$19.87K | 0 | 0 | 1 | 0 | 1 |
| HUM | HUMANA INC | -993,280 | -$286.55K | 0 | 0 | 2 | 1 | 2 |
| DHR | DANAHER CORP | -938,157 | $201.92K | 3 | 0 | 4 | 1 | 10 |
| EW | EDWARDS LIFESCIENCES CORP | -930,372 | -$46.38K | 1 | 1 | 3 | 0 | 6 |
| AUPH | AURINIA PHARMACEUTICALS INC | -918,100 | -$15.28K | 0 | 0 | 1 | 0 | 1 |
| VERU | VERU INC | -907,900 | -$3.35K | 0 | 0 | 1 | 0 | 1 |
| XRAY | DENTSPLY SIRONA INC | -855,109 | -$41.27K | 0 | 2 | 2 | 0 | 4 |
| IQV | IQVIA HOLDINGS INC | -799,125 | -$84.87K | 0 | 0 | 1 | 2 | 1 |
| WBA | WALGREENS BOOTS ALLIANCE INC | -780,322 | -$41.92K | 0 | 2 | 2 | 0 | 5 |
| THC | TENET HEALTHCARE CORP | -624,200 | -$11.16K | 0 | 0 | 1 | 0 | 1 |
| OVID | OVID THERAPEUTICS INC | -624,109 | -$4.60K | 0 | 0 | 0 | 1 | 0 |
| ARDX | ARDELYX INC | -621,520 | -$6.08K | 0 | 0 | 1 | 0 | 1 |
| VXRT | VAXART INC | -616,328 | -$5.46K | 0 | 0 | 0 | 1 | 0 |
| NVO | NOVO-NORDISK A/S-SPONS ADR | -579,281 | $73.20K | 2 | 1 | 1 | 0 | 5 |
| GMED | GLOBUS MEDICAL INC - A | -566,800 | -$26.78K | 0 | 0 | 1 | 0 | 1 |
| BKD | BROOKDALE SENIOR LIVING INC | -539,800 | -$6.60K | 0 | 0 | 1 | 0 | 1 |
| VRTX | VERTEX PHARMACEUTICALS INC | -477,048 | -$234.98K | 1 | 0 | 1 | 0 | 2 |
| HSIC | HENRY SCHEIN INC | -466,702 | -$26.71K | 0 | 0 | 2 | 1 | 3 |
| CVS | CVS HEALTH CORP | -466,543 | -$180.77K | 3 | 8 | 2 | 0 | 14 |
| ARAY | ACCURAY INC | -463,308 | $624 | 0 | 0 | 1 | 0 | 1 |
| CRL | CHARLES RIVER LABORATORIES | -451,364 | -$15.76K | 0 | 0 | 2 | 0 | 2 |
| JNJ | JOHNSON & JOHNSON | -436,064 | $98.11K | 1 | 4 | 8 | 0 | 18 |
| PGEN | PRECIGEN INC | -418,451 | -$13.35K | 0 | 0 | 1 | 2 | 1 |
| GILD | GILEAD SCIENCES INC | -402,251 | -$401.40K | 2 | 6 | 1 | 0 | 9 |
| BRKR | BRUKER CORP | -397,900 | -$16.43K | 0 | 0 | 1 | 0 | 1 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | -396,100 | -$5.30K | 0 | 0 | 1 | 0 | 1 |
| SNN | SMITH & NEPHEW PLC -SPON ADR | -394,200 | -$14.88K | 0 | 0 | 1 | 0 | 1 |
| COR | CENCORA INC | -393,746 | -$39.99K | 1 | 0 | 1 | 1 | 2 |
| TNDM | TANDEM DIABETES CARE INC | -392,332 | -$32.35K | 0 | 0 | 1 | 0 | 1 |
| ATEC | ALPHATEC HOLDINGS INC | -391,999 | -$1.81K | 0 | 0 | 1 | 0 | 1 |
| ADAP | ADAPTIMMUNE THERAPEUTICS-ADR | -383,800 | -$6.53K | 0 | 0 | 1 | 0 | 1 |
Frequently asked questions about Most sold healthcare stocks in Q3 2020
What are the most sold Healthcare stocks in Q3 2020?
The most sold healthcare stocks in Q3 2020 are those with the largest decrease in reported share counts across tracked institutional investors compared to Q2 2020, based on SEC 13F filings.
Which healthcare stocks did institutional investors trimmed or exited the most in Q3 2020?
Among the managers we track, net reductions were largest in companies such as AKEBIA THERAPEUTICS INC (AKBA), GRIFOLS SA-ADR (GRFS), ASTRAZENECA PLC-SPONS ADR (AZN), based on aggregated 13F data.
How is institutional selling calculated?
Selling is calculated by summing the net decrease in shares reported by tracked investors between two consecutive quarterly 13F snapshots (compared to Q2 2020).
Does this include all institutional owners?
These rankings are based on a subset of tracked institutional investors who file SEC 13F reports. While not exhaustive, the dataset includes many of the largest and most influential funds.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.